These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10454717)

  • 61. Myasthenia gravis: relation between jitter in single-fiber EMG and antibody to acetylcholine receptor.
    Konishi T; Nishitani H; Matsubara F; Ohta M
    Neurology; 1981 Apr; 31(4):386-92. PubMed ID: 6261187
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Application of futility analysis to refine jitter recordings in myasthenia gravis.
    Narayanaswami P; Pantoja-Galicia N; Betensky RA; Rutkove SB
    Muscle Nerve; 2012 Apr; 45(4):486-91. PubMed ID: 22431080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.
    Zhang M; Guo J; Li H; Zhou Y; Tian F; Gong L; Wang X; Li Z; Zhang W
    J Mol Neurosci; 2013 Jun; 50(2):317-23. PubMed ID: 23397576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surrogate therapeutic outcome measures in patients with myasthenia gravis.
    Zinman L; Baryshnik D; Bril V
    Muscle Nerve; 2008 Feb; 37(2):172-6. PubMed ID: 17918748
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis.
    Farrugia ME; Weir AI; Cleary M; Cooper S; Metcalfe R; Mallik A
    Muscle Nerve; 2009 May; 39(5):579-85. PubMed ID: 19260051
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis.
    Sciacca G; Reggio E; Mostile G; Nicoletti A; Drago F; Salomone S; Zappia M
    Neurol Sci; 2018 Feb; 39(2):341-345. PubMed ID: 29330628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR-30e-5p as predictor of generalization in ocular myasthenia gravis.
    Sabre L; Maddison P; Wong SH; Sadalage G; Ambrose PA; Plant GT; Punga AR
    Ann Clin Transl Neurol; 2019 Feb; 6(2):243-251. PubMed ID: 30847357
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ocular myasthenia gravis - How effective is low dose prednisone long term?
    Verma R; Wolfe GI; Kupersmith MJ
    J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recording Fewer Than 20 Potential Pairs With SFEMG May Suffice for the Diagnosis of Myasthenia Gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    J Clin Neurophysiol; 2017 Sep; 34(5):408-412. PubMed ID: 28650411
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.
    Rao J; Li S; Wang X; Cheng Q; Ji Y; Fu W; Huang H; Shi L; Wu X
    Front Med (Lausanne); 2022; 9():851808. PubMed ID: 35755064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concentric-needle single-fiber electromyography for the diagnosis of myasthenia gravis.
    Benatar M; Hammad M; Doss-Riney H
    Muscle Nerve; 2006 Aug; 34(2):163-8. PubMed ID: 16642500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunotherapy for ocular myasthenia gravis: an observational study in Japan.
    Narita T; Nakane S; Nagaishi A; Minami N; Niino M; Kawaguchi N; Murai H; Kira JI; Shimizu J; Iwasa K; Yoshikawa H; Hatanaka Y; Sonoo M; Shimizu Y; Matsuo H
    Ther Adv Neurol Disord; 2023; 16():17562864231163819. PubMed ID: 37051222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stimulation SFEMG in myasthenia gravis.
    Jabre JF; Chirico-Post J; Weiner M
    Muscle Nerve; 1989 Jan; 12(1):38-42. PubMed ID: 2747735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
    Isshiki Y; Mimura O; Gomi F
    Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical features of double seronegative ocular myasthenia gravis.
    Goto T; Kimura A; Masuda A; Mochizuki Y; Gomi F
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2617-2623. PubMed ID: 38416235
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic yield of stimulation and voluntary single-fiber electromyography in myasthenia gravis.
    Murga L; Sánchez F; Menéndez C; Castilla JM
    Muscle Nerve; 1998 Aug; 21(8):1081-3. PubMed ID: 9655130
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular Manifestations.
    Peragallo JH; Bitrian E; Kupersmith MJ; Zimprich F; Whittaker TJ; Lee MS; Bruce BB
    J Neuroophthalmol; 2016 Mar; 36(1):29-32. PubMed ID: 26035808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.